Corona virus. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Control group: Patients in the control group are treated with Hydroxychloroquine sulfate and Azithromycin (if there is no cardiac contraindication) according to the protocol of the Min
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients 18 to 50 years Infected by the COVID 19 virus Patients with clinical symptoms, history of exposure to the patient and a positive RT-PCR test for Covid 19 from A laboratory or characteristic signs on a CT scan of the chest) with mild to moderate clinical manifestations according to the National Early Warning Score (NEWS) (mild: 1-4 / moderate: 5-6) Obtaining informed written consent consciously
Exclusion criteria
Exclusion criteria: Severely ill and hospitalized in the intensive care unit Patients who are unable to take oral medications Patients with AST / ALT levels more than 5 times above normal Pregnant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improving clinical symptoms. Timepoint: Daily. Method of measurement: National Early Warning Score? (NEWS).;Reducing the length of hospitalization. Timepoint: Daily. Method of measurement: Counting.;Improving paraclinical indicators of the disease. Timepoint: Daily lymphocyte count - the last day of hospital CT scan. Method of measurement: Lymphocyte count - CT scan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lack of response to treatment and hospitalization in the ICU. Timepoint: Daily. Method of measurement: Assessing clinical manifestations. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbolfazl Zendehdel
Tehran University of Medical Sciences
Outcome results
None listed